Skip to main navigation Skip to search Skip to main content

Smoking and comorbidities in rheumatoid arthritis: what we know and what we can do

Research output: Contribution to journalArticlepeer-review

Abstract

Cigarette smoking continues to be a major health hazard contributing significantly to morbidity and mortality worldwide. Cigarette smoking is a shared risk factor for rheumatoid arthritis (RA) and many of its comorbidities. Consequently, RA patients suffer the morbidity of cumulative disease burden as well as excess mortality. This review explores and summarizes existing evidence of the complex interplay between smoking and common comorbidities in rheumatoid arthritis including cardiovascular disease, respiratory disease, malignancies, osteoporosis and periodontitis. As disease modifying therapies continue to reduce direct disability from RA, there is increasingly greater scope to improve quality and duration of life by optimizing comorbid diseases. Smoking cessation advice should feature in all consultations.
Original languageEnglish
Pages (from-to)45-53
Number of pages9
JournalInternational Journal of Clinical Rheumatology
Volume10
Issue number1
DOIs
Publication statusPublished - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Smoking and comorbidities in rheumatoid arthritis: what we know and what we can do'. Together they form a unique fingerprint.

Cite this